Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs

International Journal of Cardiology

Volumn 156, Issue 3, 2012, Pages 323-325

  Biermann, Janine ^a,b   Neumann, Till ^a   Angermann, Christiane E ^c   Erbel, Raimund ^a   Maisch, Bernhard ^d   Pittrow, David ^e   Regitz Zagrosek, Vera ^f   Scheffold, Thomas ^g   Wachter, Rolf ^h   Gelbrich, Götz ⁱ   Wasem, Jürgen ^b   Neumann, Anja ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF WITTEN HERDECKE   (Germany)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Costs; Economic evaluation; Etiology; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; CONGESTIVE CARDIOMYOPATHY; CONSULTATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIASTOLIC BLOOD PRESSURE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEART DISEASE; HEART REHABILITATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSIVE HEART DISEASE; HYPERTROPHIC CARDIOMYOPATHY; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE;

EID: 84859795306     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.099     Document Type: Article

References (23)

1. Cleland JGF, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63. (Pubitemid 36286187)
2. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-74. (Pubitemid 36286188)
3. Cleland JG, Khand AU, Clark AL. The heart failure epidemic: exactly how big is it? Eur Heart J 2001;22:623-6. (Pubitemid 32622421)
4. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart Disease and Stroke Statistics -2010 update: a report from the American Heart Association. Circulation 2010;121: e46-e215.
5. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41.
6. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
7. Cowie MR, Zaphiriou A. Recent developments: management of chronic heart failure. Br Med J 2002;325:422-5. (Pubitemid 34969793)
8. Biermann J, Neumann A, Hewer A, Wasem J, Erbel R, Neumann T. Influence of the demographic change on hospital admissions and costs in Germany. Med Klin 2010;105:876-81.
9. Mehrhof F, Löffler M, Gelbrich G, et al. A network against failing hearts- introducing the German "Competence Network Heart Failure". Int J Cardiol 2010;145:135-8.
10. Krauth C, Hessel F, Hansmeier T,Wasem J, Seitz R, Schweikert B. Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005;67:736-46. (Pubitemid 41604934)
11. Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 2010: Aktuelle Daten, Kosten, Trends und Kommentare. Berlin/Heidelberg/New York: Springer-Verlag; 2010.
12. Neumann T, Biermann J, Neumann A, et al. Heart failure: the commonest reason for hospital admission in Germany. Dtsch Arztebl Int 2009;106:269-75.
13. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-71. (Pubitemid 35190362)
14. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail 2001;3:283-91. (Pubitemid 32895835)
15. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008;52:428-34. (Pubitemid 352040814)
16. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A Policy statement from the American Heart Association. Circulation 2011;123:933-44.
17. Lorgelly PK, Briggs AH, Wedel H, et al. An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. Eur J Heart Fail 2010;12:66-74.
18. Klersy C, De Silvestri A, Gabutti G, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail 2011;13:450-9.
19. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press; 2001. p. 68-93.
20. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. p. 176-213.
21. Szucs TD. Gesundheitsökonomische Aspekte der chronischen Herzinsuffizienz. Teil 1: Krankheitslast und ökonomische Bewertung. Schweiz Ärzteztg 2003;84:2431-5.
22. Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies -report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90-7. (Pubitemid 36403125)
23. Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H. Retrospective economic and outcomes analyses using non-US databases: a review. Pharmacoeconomics 2007;25:563-76. (Pubitemid 47048040)